
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13
Shenxiang Liu, Mei Huang, Zhiqin Chen, et al.
Experimental Cell Research (2020) Vol. 389, Iss. 1, pp. 111894-111894
Closed Access | Times Cited: 55
Shenxiang Liu, Mei Huang, Zhiqin Chen, et al.
Experimental Cell Research (2020) Vol. 389, Iss. 1, pp. 111894-111894
Closed Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 141
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 141
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Yangchan Li, Rui Su, Xiaolan Deng, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 598-614
Open Access | Times Cited: 140
Yangchan Li, Rui Su, Xiaolan Deng, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 598-614
Open Access | Times Cited: 140
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 121
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 121
FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability
Yawei Xu, Jingcheng Zhou, Lei Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5943-5962
Open Access | Times Cited: 59
Yawei Xu, Jingcheng Zhou, Lei Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5943-5962
Open Access | Times Cited: 59
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Shun Li, D. Mark Pritchard, Lu‐Gang Yu
Cancers (2022) Vol. 14, Iss. 13, pp. 3263-3263
Open Access | Times Cited: 44
Shun Li, D. Mark Pritchard, Lu‐Gang Yu
Cancers (2022) Vol. 14, Iss. 13, pp. 3263-3263
Open Access | Times Cited: 44
DNA adenine methylation in eukaryotes: Enzymatic mark or a form of DNA damage?
Matthias Bochtler, Humberto Fernandes
BioEssays (2020) Vol. 43, Iss. 3
Open Access | Times Cited: 50
Matthias Bochtler, Humberto Fernandes
BioEssays (2020) Vol. 43, Iss. 3
Open Access | Times Cited: 50
<p>The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers</p>
Jinyan Wang, Lijuan Chen, Ping Qiang
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12845-12856
Open Access | Times Cited: 43
Jinyan Wang, Lijuan Chen, Ping Qiang
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12845-12856
Open Access | Times Cited: 43
N6-Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review
Sha Wu, Xiaofeng Li, Yuanyuan Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Sha Wu, Xiaofeng Li, Yuanyuan Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
Bo Qin, Qian Bai, Dan Yan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1995-2003
Open Access | Times Cited: 23
Bo Qin, Qian Bai, Dan Yan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1995-2003
Open Access | Times Cited: 23
m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2
Wei Wang, Ying He, Lulu Zhai, et al.
Epigenetics (2022) Vol. 17, Iss. 12, pp. 1738-1752
Open Access | Times Cited: 22
Wei Wang, Ying He, Lulu Zhai, et al.
Epigenetics (2022) Vol. 17, Iss. 12, pp. 1738-1752
Open Access | Times Cited: 22
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma
Qiwei Yang, Ayman Al‐Hendy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7957-7957
Open Access | Times Cited: 11
Qiwei Yang, Ayman Al‐Hendy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7957-7957
Open Access | Times Cited: 11
Regulatory mechanisms of m6A RNA methylation in esophageal cancer: a comprehensive review
Long Wen, Jiang Fu, Zixu Wang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Long Wen, Jiang Fu, Zixu Wang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
The regulatory role of m6A in cancer metastasis
Ying Zhou, Peng Cao, Qing Zhu
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Ying Zhou, Peng Cao, Qing Zhu
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Silencing METTL3 and YTHDF2 Increases HSP70 Expression and Promotes Corneal Epithelial Healing.
Yapeng Jing, Jun Li, Yi Guan, et al.
Experimental Eye Research (2025), pp. 110419-110419
Closed Access
Yapeng Jing, Jun Li, Yi Guan, et al.
Experimental Eye Research (2025), pp. 110419-110419
Closed Access
Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer
Mingxin Zhang, Minghua Bai, Li Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Mingxin Zhang, Minghua Bai, Li Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner
Kaiping Deng, Zhen Zhang, Caifang Ren, et al.
Experimental Cell Research (2021) Vol. 401, Iss. 2, pp. 112524-112524
Closed Access | Times Cited: 24
Kaiping Deng, Zhen Zhang, Caifang Ren, et al.
Experimental Cell Research (2021) Vol. 401, Iss. 2, pp. 112524-112524
Closed Access | Times Cited: 24
Function and clinical significance of N6-methyladenosine in digestive system tumours
Junchao Huang, Yingjie Shao, Wendong Gu
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Junchao Huang, Yingjie Shao, Wendong Gu
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Identification of clinical prognostic features of esophageal cancer based on m6A regulators
Huimei Wang, Yiping Zhang, Lin Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Huimei Wang, Yiping Zhang, Lin Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential
Yuting Sun, De Jin, Ziwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194967-194967
Open Access | Times Cited: 10
Yuting Sun, De Jin, Ziwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194967-194967
Open Access | Times Cited: 10
Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus
P. J. Jayasree, Shalmoli Dutta, Pragati Karemore, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3042-3058
Closed Access | Times Cited: 10
P. J. Jayasree, Shalmoli Dutta, Pragati Karemore, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3042-3058
Closed Access | Times Cited: 10
The METTL3-m6A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma
Yue Qiu, Zhen Tian, Tingyu Miao, et al.
Gene (2024) Vol. 908, pp. 148281-148281
Closed Access | Times Cited: 3
Yue Qiu, Zhen Tian, Tingyu Miao, et al.
Gene (2024) Vol. 908, pp. 148281-148281
Closed Access | Times Cited: 3
Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation
Bo Qin, Meng Dong, Zhengyang Wang, et al.
Oncology Reports (2020)
Open Access | Times Cited: 24
Bo Qin, Meng Dong, Zhengyang Wang, et al.
Oncology Reports (2020)
Open Access | Times Cited: 24
Recent advances of m6A methylation modification in esophageal squamous cell carcinoma
Xiaoqing Zhang, Ning Lü, Li Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Xiaoqing Zhang, Ning Lü, Li Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy
Subhadra Kumari, Santosh Kumar, Srinivasan Muthuswamy
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 4, pp. 1621-1633
Closed Access | Times Cited: 15
Subhadra Kumari, Santosh Kumar, Srinivasan Muthuswamy
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 4, pp. 1621-1633
Closed Access | Times Cited: 15
m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
Dong Xiao, T. Fang, Lei Ye, et al.
Aging (2021) Vol. 13, Iss. 17, pp. 21497-21512
Open Access | Times Cited: 20
Dong Xiao, T. Fang, Lei Ye, et al.
Aging (2021) Vol. 13, Iss. 17, pp. 21497-21512
Open Access | Times Cited: 20